首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >An improved microalbumin method (µALB_2) with extended analytical measurement range evaluated on the ADVIA® chemistry systems
【2h】

An improved microalbumin method (µALB_2) with extended analytical measurement range evaluated on the ADVIA® chemistry systems

机译:改进的微量白蛋白方法(µALB_2)具有扩展的分析测量范围可通过ADVIA®化学系统进行评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Quantitative determination of albumin (ALB) in human urine is important to assess kidney functions in a variety of diseases. Recently, Siemens released an improved Microalbumin assay (µALB_2) to measure urinary ALB on the automated, random access ADVIA 1650/1800, ADVIA 2400, and ADVIA 1200 Chemistry Systems. We evaluated analytical performances of this new method. All ADVIA Chemistry Systems use the same microalbumin reagent packs, µALB_2 calibrators, and commercial controls. The within‐run and total CVs of the improved method with two‐level BioRad Liquichek Urine Chemistry controls (∼2 and 9 mg/dl ALB) and a urine pool (∼29 mg/dl ALB) on all ADVIA Chemistry systems were <4.1 and <6.1%, respectively (40 replicates per sample). The analytical range/linearity of the method (all ADVIA systems) was from 0.3 mg/dl to theALB concentration in the highest level of calibrator (∼38–42 mg/dl). The improved method (µALB_2) on the ADVIA 1650/1800 ( ) correlated well with both the Beckman DXC 800 Microalbumin and the old microalbumin method on the ADVIA 1650/1800 analyzers. The improved method showed <10% interference with 16 chemicals from acetaminophen to uric acid that may be present in urine. The improved method has a minimum of 60 days' on‐system stability on all systems with the calibration frequencies of (with/without a Reagent Container insert) 20/30 days (ADVIA1200), 50/60 days (ADVIA1650/1800), and 20/60 days (ADVIA2400). No prozone was observed with the method on any platform up to the highest ALB concentration tested in a sample (4,000 mg/dl). J. Clin. Lab. Anal. 23:314–318, 2009. © 2009 Wiley‐Liss, Inc.
机译:人体尿液中白蛋白(ALB)的定量测​​定对于评估各种疾病的肾脏功能非常重要。最近,西门子发布了一种改进的微量白蛋白测定法(µALB_2),用于在自动随机访问的ADVIA 1650/1800,ADVIA 2400和ADVIA 1200化学系统上测量尿液ALB。我们评估了这种新方法的分析性能。所有ADVIA化学系统均使用相同的微量白蛋白试剂盒,µALB_2校准物和市售对照品。在所有ADVIA Chemistry系统上,采用两级BioRad Liquichek尿液化学控制(约2和9μmg/ dl ALB)和尿液池(约29μmg/ dl ALB)的改进方法的运行内和总CV均<4.1。和分别<6.1%(每个样品重复40次)。该方法(所有ADVIA系统)的分析范围/线性为0.3µmg / dl至最高校准物水平(〜38–42µmg / dl)的ALB浓度。 ADVIA 1650/1800()上的改进方法(µALB_2)与Beckman DXC 800微量白蛋白法和ADVIA 1650/1800分析仪上的旧微量白蛋白法紧密相关。改进的方法显示对尿液中可能存在的从对乙酰氨基酚到尿酸的16种化学物质的干扰小于10%。改进后的方法在所有系统上的系统稳定性至少达到60天,校准频率为(带/不带试剂容器插件)20/30天(ADVIA1200),50/60天(ADVIA1650 / 1800)和20/60天(ADVIA2400)。直到样品中测试的最高ALB浓度(4,000 mg / dl),该方法在任何平台上均未观察到前zone。 J.临床实验室肛门2009年23:314–318。©2009 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号